Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Why Blackstone Group LP (BX) Stock Is Jumping Today

Blackstone (BX) stock was up on Monday after the company's announcement of a new infrastructure investment vehicle and business.

Should You Buy Sears Holding Corp (SHLD) Stock? 3 Pros, 3 Cons

Sears stock has recovered somewhat, but the company's troubles remain. Is there a case for holding SHLD stock anyways?

Why Square Inc (SQ) Stock Is a Big, Screaming Buy

Square's potential is massive amid a still-growing payment processing industry, here and abroad. Keep chasing SQ stock higher.

Can Amazon.com, Inc. (AMZN) Stop Wayfair Inc (W) Stock in Its Tracks?

Ultimately AMZN might one day manage to build a supply network to rival Wayfair in the home furnishings space ... but not right now.

Buy Alibaba Group Holding Ltd (BABA) Stock at Your Own Risk

Alibaba did deliver an excellent Q4 report a couple weeks back, but investors are ignoring some big risks in high-flying BABA stock.

Amgen, Inc. (AMGN) Stock Dips on Osteoporosis Drug Disappointment

Amgen (AMGN) stock was down on Monday after the biotechnology company reported serious adverse events during its Phase 3 Evenity Arch study.

Freeport-McMoRan Inc (FCX) Stock Isn’t an Investment

Freeport-McMoRan (FCX) has been one roller coaster of boom-and-bust. With more problems just around the corner, FCX stock remains simply a trade.

Puma Biotechnology Inc (PBYI) Pops 60% on FDA Review

An FDA review of Puma Biotechnology's breast cancer drug neratinib had mercifully few fireworks, prompting a surge in PBYI stock.

Take-Two Interactive (TTWO) Stock Is Not the Bargain You’re Looking For

Take-Two Interactive (TTWO) is cheaper than its peers and it is up big in 2017. Still, it's tough to be a buyer of TTWO stock right now.

Cumberland Pharmaceuticals, Inc. (CPIX) and Recro Pharma Inc (REPH) Lead 9 Notable Investor Filings

13G and 13D filings are windows into activist investor activity. We look at Cumberland Pharmaceuticals, Recro Pharma and 7 others

Should You Buy Advanced Micro Devices, Inc. (AMD) Stock? 3 Pros, 3 Cons

AMD stock's recovery has hit some speed-bumps. Is this merely a pause in Advanced Micro Devices' rally, or will short sellers finally have their revenge?

Is the Snap Inc (SNAP) Stock Bounce for Real?

Snapchat parent Snap is showing promise on its early charts. Will the fundamentals eventually justify a long-term bull case for SNAP stock?

Why Apple Inc. (AAPL) Stock Is Vulnerable Right Now

AAPL stock is up 60% in the last year, bringing its P/E in line with the market. The problem? Apple's results have improved only slightly.

Is Chipotle Mexican Grill, Inc. (CMG) Stock Entering Buy Territory?

Chipotle Mexican Grill (CMG) is improving its operations and putting the E. coli outbreak behind it. CMG stock looks set for a comeback.

Adeptus Health Inc (ADPT) and Kate Spade & Co (KATE) Lead 18 Activist Investor Filings

13D and 13G filings are windows into the world of activist investor activity. We look at Kate Spade & Co and 10 other recent filings

10 Mergers & Acquisitions Investors Would Love to See

Mergers & acquisitions aren’t happening nearly as often as in past years, but that won't stop investors from daydreaming.

3 Earnings Reports That Are on Tap Next Week

Earnings season is winding down, but three companies -- Take Two (TTWO), GameStop (GME) and Momo (MOMO) -- are on tap to report results.

McKesson Corporation (MCK) Shares Fly on Earnings Beat, Upbeat Forecast

McKesson (MCK) stock was sitting pretty on Friday following the release of its earnings report for its fiscal fourth quarter of 2017.

GlycoMimetics Inc (GLYC) Stock May Find Its Way to Profitability

It's not a household name, but GlycoMimetics is now on the fast track to profits, giving GLYC stock a much-needed boost.